| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Magnetar Financial LLC | 7.5% | $13,325,000 | 1,300,000 | MAGNETAR FINANCIAL LLC | 31 Dec 2024 |
As of 30 Sep 2025, 7 institutional investors reported holding 1,509,117 shares of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU). This represents 8.7% of the company’s total 17,264,276 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1,509,117 | $15,804,316 | -$9,094,416 | $10.40 | 7 |
| 2025 Q2 | 2,390,883 | $24,722,130 | -$18,828,233 | $10.30 | 9 |
| 2025 Q1 | 4,407,963 | $44,695,553 | -$106,490,182 | $10.14 | 21 |
| 2024 Q4 | 15,028,755 | $150,646,354 | +$149,794,654 | $10.02 | 42 |